Search

Your search keyword '"MOREL H"' showing total 19 results

Search Constraints

Start Over You searched for: Author "MOREL H" Remove constraint Author: "MOREL H" Database Academic Search Index Remove constraint Database: Academic Search Index
19 results on '"MOREL H"'

Search Results

1. Évaluation de l'efficacité à 1 an d'une prise en charge globale de la gonarthrose proposée au sein d'une unité d'hospitalisation de jour.

2. Extracellular volume measurements using bioimpedance spectroscopy-Hanai method and wrist-ankle resistance at 50 kHz.

3. Les recommandations sur le suivi de l'asthmatique adulte et adolescent : quels critères de suivi ?

4. In vitro bicarbonate and urea kinetics during hemodialysis and online hemodiafiltration.

5. Added value of buccal cell FISH analysis in the diagnosis and management of Turner syndrome.

6. Failure degradation similarities on power SiC MOSFET devices submitted to short-circuit stress and accelerated switching conditions.

8. Electrical, thermal and mechanical properties of poly-etherimide epoxy-diamine blend.

9. 1292P A national real-world analysis of ROS1+ metastatic non-small cell lung cancer patients management (explore ALK, cohort 2, GFPC 03-2019).

10. Analysis of the dynamic avalanche of punch through insulated gate bipolar transistor (PT-IGBT)

11. Electro-thermal simulation including a temperature distribution inside power semiconductor devices.

12. Infections caused by naturally AmpC-producing Enterobacteriaceae: Can we use third-generation cephalosporins? A narrative review.

13. Extraction of the 4H-SiC/SiO2 Barrier Height Over Temperature.

14. 1097P Impact of tumor and liquid rebiopsy in metastatic non-small cell lung cancer with EGFR/ALK/ROS oncogenic drivers, progressing after optimal target therapy.

15. 1016P GFPC 06-2018: A multicentre phase II, open-label, non-randomized study evaluating platinum-pemetrexed-atezolizumab (+/- bevacizumab) for patients with stage IIIB/IV non-squamous NSCLC with EGFR mutation, ALK rearrangement or ROS1 fusion progressing after targeted therapies

16. Comparaison d’un suivi nutritionnel précoce formalisé à une prise en charge ponctuelle dans le cancer du poumon.

17. New definition of critical energy for SiC MOSFET robustness under short circuit operations: The repetitive critical energy.

18. 1326P Liver metastasis but not bone metastasis impact overall survival of advanced non-small cell lung cancer (NSCLC) treated by nivolumab (GFPC 04-2016).

19. 1273P Durvalumab (D) compared to maintenance chemotherapy (SoC) in patients (pts) with metastatic non-small cell lung cancer (NSCLC): Results from the randomized SAFIR02 LUNG-IMMUNO trial.

Catalog

Books, media, physical & digital resources